NANCY HESSE was named chief nursing officer of Cancer Treatment Centers of America.
CITY OF HOPE launched a stem cell therapy clinic. The Alpha Clinic for Cell Therapy and Innovation is funded by an $8 million, five-year grant from the California Institute for Regenerative Medicine.
STEVEN FINKELSTEIN was appointed national chief science officer of 21st Century Oncology.
DAVID NATHAN is the first recipient of the Boston Children's Hospital Lifetime Impact Award at the hospital's second annual Global Pediatric Innovation Summit.
THE CANCER INNOVATION COALITION held a policy briefing on Capitol Hill, calling for legislative and regulatory action in 2015 to be focused on U.S. cancer research.
THE AMERICAN CANCER SOCIETY's Pennsylvania Division, Southeast Region, recently honored researchers at Fox Chase Cancer Center and Temple University School of Medicine.
MERIDIAN HEALTH and Hackensack University Health Network agreed to enter into discussions to merge the health systems that will result in one, integrated health care delivery system.
CITY OF HOPE launched an institute focused on treating blood and bone marrow diseases: the Hematologic Malignancies and Stem Cell Transplantation Institute.
THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY endorsed a guideline published by the American Urological Association and the American Society for Radiation Oncology on the use of adjuvant and salvage radiotherapy after prostatectomy. The endorsement was published in the Journal of Clinical Oncology.
APTOSE BIOSCIENCES Inc. joined the Beat AML collaboration, developed by The Leukemia & Lymphoma Society and the Knight Cancer Institute at Oregon Health & Science University.
